These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28107588)

  • 1. Mitochondrial uncoupler exerts a synthetic lethal effect against β-catenin mutant tumor cells.
    Shikata Y; Kiga M; Futamura Y; Aono H; Inoue H; Kawada M; Osada H; Imoto M
    Cancer Sci; 2017 Apr; 108(4):772-784. PubMed ID: 28107588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MGAT1 is a novel transcriptional target of Wnt/β-catenin signaling pathway.
    Akiva I; Birgül Iyison N
    BMC Cancer; 2018 Jan; 18(1):60. PubMed ID: 29310626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
    Sun H; Gao Y; Lu K; Zhao G; Li X; Li Z; Chang H
    World J Surg Oncol; 2015 Oct; 13():307. PubMed ID: 26499380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.
    Yin Y; Li F; Li S; Cai J; Shi J; Jiang Y
    Cell Physiol Biochem; 2017; 42(2):469-479. PubMed ID: 28578348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effect of LATS2 on liver cancer death: Role of DRP1-mediated mitochondrial division and the Wnt/β-catenin pathway.
    Zhang L; Li S; Wang R; Chen C; Ma W; Cai H
    Biomed Pharmacother; 2019 Jun; 114():108825. PubMed ID: 30981110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GL-V9 induced upregulation and mitochondrial localization of NAG-1 associates with ROS generation and cell death in hepatocellular carcinoma cells.
    Zhang X; Kang Y; Huo T; Tao R; Wang X; Li Z; Guo Q; Zhao L
    Free Radic Biol Med; 2017 Nov; 112():49-59. PubMed ID: 28697922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of dinactin, a macrolide antibiotic, as a natural product-based small molecule targeting Wnt/β-catenin signaling pathway in cancer cells.
    Hussain A; Dar MS; Bano N; Hossain MM; Basit R; Bhat AQ; Aga MA; Ali S; Hassan QP; Dar MJ
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):551-559. PubMed ID: 31129716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
    Wei W; Chua MS; Grepper S; So S
    Int J Cancer; 2010 May; 126(10):2426-36. PubMed ID: 19662654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid.
    Delgado E; Bahal R; Yang J; Lee JM; Ly DH; Monga SP
    Curr Cancer Drug Targets; 2013 Oct; 13(8):867-78. PubMed ID: 23822752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
    Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TTK Inhibitors as a Targeted Therapy for
    Zaman GJR; de Roos JADM; Libouban MAA; Prinsen MBW; de Man J; Buijsman RC; Uitdehaag JCM
    Mol Cancer Ther; 2017 Nov; 16(11):2609-2617. PubMed ID: 28751540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK interacts with β-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment.
    Park SY; Lee YK; Kim HJ; Park OJ; Kim YM
    Oncol Rep; 2016 Mar; 35(3):1566-72. PubMed ID: 26707164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
    Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miclxin, a Novel MIC60 Inhibitor, Induces Apoptosis via Mitochondrial Stress in β-Catenin Mutant Tumor Cells.
    Ikeda H; Muroi M; Kondoh Y; Ishikawa S; Kakeya H; Osada H; Imoto M
    ACS Chem Biol; 2020 Aug; 15(8):2195-2204. PubMed ID: 32584541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urolithin B suppresses tumor growth in hepatocellular carcinoma through inducing the inactivation of Wnt/β-catenin signaling.
    Lv MY; Shi CJ; Pan FF; Shao J; Feng L; Chen G; Ou C; Zhang JF; Fu WM
    J Cell Biochem; 2019 Oct; 120(10):17273-17282. PubMed ID: 31218741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
    Canal F; Anthony E; Lescure A; Del Nery E; Camonis J; Perez F; Ragazzon B; Perret C
    BMC Cancer; 2015 Dec; 15():1020. PubMed ID: 26715116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
    Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.